FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024993361> ?p ?o ?g. }

• W2024993361 endingPage "682" @default.
• W2024993361 startingPage "677" @default.
• W2024993361 abstract "1. A specific and efficient liquid chromatography–mass spectrometry (LC-MS) method was established for monitoring patient plasma cyclophosphamide levels in a phase I trial of an oral cyclophosphamide-based combination chemotherapy regimen. 2. An Agilent 1100 Series LC-MSD system (Agilent Technologies, Avondale, PA, USA), with a single quadrupole mass detector using a positive atmospheric pressure chemical ionization (APCI) interface and single ion monitoring at m/z 261, was used. Chromatography was performed using a LUNA C8 5 µm 30 × 4.6 mm stainless steel column (Phenomenex, Torrance, CA, USA) and a mobile phase of aqueous acetonitrile pumped at a flow rate of 0.7 mL/min. High-throughput solid-phase sample extraction was performed using a Gilson ASPEC XL4 system (Gilson Medical, Middleton, WI, USA) controlled by prestored programs. 3. The standard curve for cyclophosphamide was linear over the concentration range 0.026–1.08 µg/mL (r2 > 0.994). Intra- and interassay accuracy and precision were 97–107 and 3–10%, respectively. The limit of detection was determined to be 0.01 µg/mL. Single ion monitoring at m/z 261 provided a high degree of specificity without interference from the matrix or other chemotherapy drugs. 4. Automated sample processing allowed the analysis of a large number of plasma samples from a clinical trial of repeated daily oral dosing of cyclophosphamide. One hour after dosing, cyclophosphamide was detected in 98 of 106 plasma specimens at concentrations ranging between 0.03 and 4.88 µg/mL. Twenty-four hours after dosing, cyclophosphamide was detected in 72 of 77 plasma specimens at concentrations ranging between 0.06 and 3.13 µg/mL. There were no time-dependent changes in cyclophosphamide concentration during the 43 day period of repeated daily oral dosing. There was no correlation between cyclophosphamide dose and plasma concentration, despite the wide range of doses given in the clinical trial (50–125 mg/m2). 5. We conclude that a solid-phase extraction LC-MS technique was validated for determining cyclophosphamide in human plasma. Interoccasion variability in the rate of oral absorption and in the clearance of systemically available drug may have contributed to the wide range of cyclophosphamide concentrations found at 1 and 24 h after tablet ingestion." @default.
• W2024993361 created "2016-06-24" @default.
• W2024993361 creator A5005021921 @default.
• W2024993361 creator A5016932911 @default.
• W2024993361 creator A5016954231 @default.
• W2024993361 creator A5038498358 @default.
• W2024993361 creator A5046335734 @default.
• W2024993361 creator A5080066041 @default.
• W2024993361 creator A5082235252 @default.
• W2024993361 creator A5088930878 @default.
• W2024993361 date "2004-10-01" @default.
• W2024993361 modified "2023-10-10" @default.
• W2024993361 title "Application of liquid chromatography-mass spectrometry to monitoring plasma cyclophosphamide levels in phase I trial cancer patients*" @default.
• W2024993361 cites W1723350107 @default.
• W2024993361 cites W1973260414 @default.
• W2024993361 cites W1985609633 @default.
• W2024993361 cites W2003896724 @default.
• W2024993361 cites W2016551917 @default.
• W2024993361 cites W2058928103 @default.
• W2024993361 cites W2065325648 @default.
• W2024993361 cites W2071435841 @default.
• W2024993361 cites W2073371839 @default.
• W2024993361 cites W2137235663 @default.
• W2024993361 cites W2140690834 @default.
• W2024993361 doi "https://doi.org/10.1111/j.1440-1681.2004.03065.x" @default.
• W2024993361 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15554907" @default.
• W2024993361 hasPublicationYear "2004" @default.
• W2024993361 type Work @default.
• W2024993361 sameAs 2024993361 @default.
• W2024993361 citedByCount "19" @default.
• W2024993361 countsByYear W20249933612013 @default.
• W2024993361 countsByYear W20249933612015 @default.
• W2024993361 countsByYear W20249933612018 @default.
• W2024993361 countsByYear W20249933612019 @default.
• W2024993361 countsByYear W20249933612022 @default.
• W2024993361 countsByYear W20249933612023 @default.
• W2024993361 crossrefType "journal-article" @default.
• W2024993361 hasAuthorship W2024993361A5005021921 @default.
• W2024993361 hasAuthorship W2024993361A5016932911 @default.
• W2024993361 hasAuthorship W2024993361A5016954231 @default.
• W2024993361 hasAuthorship W2024993361A5038498358 @default.
• W2024993361 hasAuthorship W2024993361A5046335734 @default.
• W2024993361 hasAuthorship W2024993361A5080066041 @default.
• W2024993361 hasAuthorship W2024993361A5082235252 @default.
• W2024993361 hasAuthorship W2024993361A5088930878 @default.
• W2024993361 hasConcept C113196181 @default.
• W2024993361 hasConcept C119128265 @default.
• W2024993361 hasConcept C141071460 @default.
• W2024993361 hasConcept C162356407 @default.
• W2024993361 hasConcept C185592680 @default.
• W2024993361 hasConcept C2776694085 @default.
• W2024993361 hasConcept C2776755627 @default.
• W2024993361 hasConcept C43617362 @default.
• W2024993361 hasConcept C64489805 @default.
• W2024993361 hasConcept C71924100 @default.
• W2024993361 hasConceptScore W2024993361C113196181 @default.
• W2024993361 hasConceptScore W2024993361C119128265 @default.
• W2024993361 hasConceptScore W2024993361C141071460 @default.
• W2024993361 hasConceptScore W2024993361C162356407 @default.
• W2024993361 hasConceptScore W2024993361C185592680 @default.
• W2024993361 hasConceptScore W2024993361C2776694085 @default.
• W2024993361 hasConceptScore W2024993361C2776755627 @default.
• W2024993361 hasConceptScore W2024993361C43617362 @default.
• W2024993361 hasConceptScore W2024993361C64489805 @default.
• W2024993361 hasConceptScore W2024993361C71924100 @default.
• W2024993361 hasIssue "10" @default.
• W2024993361 hasLocation W20249933611 @default.
• W2024993361 hasLocation W20249933612 @default.
• W2024993361 hasOpenAccess W2024993361 @default.
• W2024993361 hasPrimaryLocation W20249933611 @default.
• W2024993361 hasRelatedWork W1980714464 @default.
• W2024993361 hasRelatedWork W1985946749 @default.
• W2024993361 hasRelatedWork W2008473017 @default.
• W2024993361 hasRelatedWork W2021697275 @default.
• W2024993361 hasRelatedWork W2047217903 @default.
• W2024993361 hasRelatedWork W2073643440 @default.
• W2024993361 hasRelatedWork W2086713653 @default.
• W2024993361 hasRelatedWork W2088956065 @default.
• W2024993361 hasRelatedWork W2340535554 @default.
• W2024993361 hasRelatedWork W2362001173 @default.
• W2024993361 hasVolume "31" @default.
• W2024993361 isParatext "false" @default.
• W2024993361 isRetracted "false" @default.
• W2024993361 magId "2024993361" @default.
• W2024993361 workType "article" @default.